Bacterial coinfection is associated with severity of avian influenza A (H7N9), and procalcitonin is a useful marker for early diagnosis

Diagnostic Microbiology and Infectious Disease

Volumn 84, Issue 2, 2016, Pages 165-169

  Yang, Meifang ^a,b   Gao, Hainv ^a,b   Chen, Jiajia ^a,b   Xu, Xiaowei ^a,b   Tang, Lingling ^a,b   Yang, Yida ^a,b   Liang, Weifeng ^a,b   Yu, Liang ^a,b   Sheng, Jifang ^a,b   Li, Lanjuan ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Bacterial co infection; H7N9; Influenza A; Mortality; Procalcitonin

Indexed keywords

BETA LACTAM; BETA LACTAM ANTIBIOTIC; C REACTIVE PROTEIN; CARBAPENEM; D DIMER; LACTATE DEHYDROGENASE; OSELTAMIVIR; PERAMIVIR; PROCALCITONIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN; CALCA PROTEIN, HUMAN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; PROTEIN PRECURSOR;

ADULT; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; COMORBIDITY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; INFLUENZA A; INFLUENZA A VIRUS (H7N9); MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SHOCK; STAPHYLOCOCCUS AUREUS; ANIMAL; BACTERIAL INFECTIONS; BLOOD; COINFECTION; COMPLICATION; INFLUENZA; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BACTERIAL INFECTIONS; CALCITONIN; CALCITONIN GENE-RELATED PEPTIDE; COINFECTION; EARLY DIAGNOSIS; FEMALE; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84954162379     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.10.018     Document Type: Article

References (27)

1. Bacterial co-infections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009, 58(38):1071-1074.
2. Chalmers J.D., Taylor J.K., Mandal P., Choudhury G., Singanayagam A., Akram A.R., et al. Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. Clin Infect Dis 2011, 53(6):503-511.
3. Cilloniz C., Ewig S., Menendez R., Ferrer M., Polverino E., Reyes S., et al. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J Infect 2012, 65(3):223-230.
4. Cuquemelle E., Soulis F., Villers D., Roche-Campo F., Ara Somohano C., Fartoukh M., et al. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Med 2011, 37(5):796-800.
5. Estenssoro E., Rios F.G., Apezteguia C., Reina R., Neira J., Ceraso D.H., et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med 2010, 182(1):41-48.
6. Finelli L., Fiore A., Dhara R., Brammer L., Shay D.K., Kamimoto L., et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus co-infection. Pediatrics 2008, 122(4):805-811.
7. Gao H.N., Lu H.Z., Cao B., Du B., Shang H., Gan J.H., et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 2013, 368(24):2277-2285.
8. Gao R., Cao B., Hu Y., Feng Z., Wang D., Hu W., et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013, 368(20):1888-1897.
9. Gilbert D.N. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis 2011, 52(Suppl. 4):S346-S350.
10. Gill J.R., Sheng Z.M., Ely S.F., Guinee D.G., Beasley M.B., Suh J., et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 2010, 134(2):235-243.
11. Helferty M., Vachon J., Tarasuk J., Rodin R., Spika J., Pelletier L. Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009. CMAJ 2010, 182(18):1981-1987.
12. Huang F., Guo J., Zou Z., Liu J., Cao B., Zhang S., et al. Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients. Nat Commun 2014, 5:3595.
13. Ingram P.R., Inglis T., Moxon D., Speers D. Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care Med 2010, 36(3):528-532.
14. Kallen A.J., Brunkard J., Moore Z., Budge P., Arnold K.E., Fosheim G., et al. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med 2009, 53(3):358-365.
15. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13(10):818-829.
16. Kumar A., Zarychanski R., Pinto R., Cook D.J., Marshall J., Lacroix J., et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009, 302(17):1872-1879.
17. Li Q., Zhou L., Zhou M., Chen Z., Li F., Wu H., et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med 2014, 370(6):520-532.
18. Martin-Loeches I., Sanchez-Corral A., Diaz E., Granada R.M., Zaragoza R., Villavicencio C., et al. Community-acquired respiratory co-infection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest 2011, 139(3):555-562.
19. Mauad T., Hajjar L.A., Callegari G.D., da Silva L.F., Schout D., Galas F.R., et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010, 181(1):72-79.
20. Nguyen T., Kyle U.G., Jaimon N., Tcharmtchi M.H., Coss-Bu J.A., Lam F., et al. Co-infection with Staphylococcus aureus increases risk of severe coagulopathy in critically ill children with influenza A (H1N1) virus infection. Crit Care Med 2012, 40(12):3246-3250.
21. Patel R.B., Mathur M.B., Gould M., Uyeki T.M., Bhattacharya J., Xiao Y., et al. Demographic and clinical predictors of mortality from highly pathogenic avian influenza A (H5N1) virus infection: CART analysis of international cases. PLoS One 2014, 9(3):e91630.
22. Pfister R., Kochanek M., Leygeber T., Brun-Buisson C., Cuquemelle E., Machado M.B., et al. Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis. Crit Care 2014, 18(2):R44.
23. Rice T.W., Rubinson L., Uyeki T.M., Vaughn F.L., John B.B., Miller RR, et al. Critical illness from 2009 pandemic influenza A virus and bacterial co-infection in the United States. Crit Care Med 2012, 40(5):1487-1498.
24. von Baum H., Schweiger B., Welte T., Marre R., Suttorp N., Pletz M.W., et al. How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia. Eur Respir J 2011, 37(5):1151-1157.
25. Webb S.A., Pettila V., Seppelt I., Bellomo R., Bailey M., Cooper D.J., et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009, 361(20):1925-1934.
26. WHO risk assessment of human infection with avian influenza A(H7N9) virus Available at:. http://www.who.int/influenza/human_animal_interface/influenza_h7n9/Risk_Assessment/en/.
27. Zhang P.J., Cao B., Li X.L., Liang L.R., Yang S.G., Gu L., et al. Risk factors for adult death due to 2009 pandemic influenza A (H1N1) virus infection: a 2151 severe and critical cases analysis. Chin Med J (Engl) 2013, 126(12):2222-2228.